Fernando Hellmann argues that the Brazilian Ministry of Health Guidelines for early drug treatment of patients diagnosed with COVID-19 is not based on scientific criteria and puts the health of Brazilians at risk.
Wasem Alsabbagh shows that universal pharmacare is the natural product of the core values of Canada’s health care system and that it is cost-saving.
Since the 1960s, five national commissions have recommended universal pharmacare for Canada. The most recent of these is the detailed and strategic report of the Advisory Council on the Implementation of National Pharmacare. Now, after more than 50 years of waiting, Canada is close to adding prescription drugs to our “medicare” system. This is extremely […]